These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16792447)

  • 1. Pharmacy management methods in Canada, including lower-cost therapy for heartburn.
    Jackson M
    J Manag Care Pharm; 2006 Jun; 12(5):398-400. PubMed ID: 16792447
    [No Abstract]   [Full Text] [Related]  

  • 2. Heartburn in consumer-directed health care and the cost outcomes of therapeutic maximum allowable cost.
    Curtiss FR
    J Manag Care Pharm; 2006 Jun; 12(5):402-5; 405. PubMed ID: 16792448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a therapeutic maximum allowable cost (MAC) program on the cost and utilization of proton pump inhibitors in an employer-sponsored drug plan in Canada.
    Mabasa VH; Ma J
    J Manag Care Pharm; 2006 Jun; 12(5):371-6. PubMed ID: 16792443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OTC omeprazole for your heartburn--enormous value-for-money opportunity.
    Curtiss FR
    J Manag Care Pharm; 2004; 10(5):458-60. PubMed ID: 15369431
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dyspepsia and heartburn in primary care: a rational and economic approach].
    Labenz J
    MMW Fortschr Med; 2009 Aug; 151(34-35):47-8. PubMed ID: 19771792
    [No Abstract]   [Full Text] [Related]  

  • 6. What is heartburn worth? A cost-utility analysis of management strategies.
    Heudebert GR; Centor RM; Klapow JC; Marks R; Johnson L; Wilcox CM
    J Gen Intern Med; 2000 Mar; 15(3):175-82. PubMed ID: 10718898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects on the cost and utilization of proton pump inhibitors from adding over-the counter omeprazole to drug benefit coverage in a state employee health plan.
    Harris BN; West DS; Johnson J; Hong SH; Stowe CD
    J Manag Care Pharm; 2004; 10(5):449-55. PubMed ID: 15369428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic analysis of on-demand maintenance therapy with proton pump inhibitors in patients with non-erosive reflux disease.
    Hughes DA; Bodger K; Bytzer P; de Herdt D; Dubois D
    Pharmacoeconomics; 2005; 23(10):1031-41. PubMed ID: 16235976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of heartburn: cost considerations.
    Vakil N
    Postgrad Med; 2000 May; 107(5 Suppl):35-8; discussion 39. PubMed ID: 19667513
    [No Abstract]   [Full Text] [Related]  

  • 10. Clopidogrel versus aspirin and esomeprazole to prevent recurrent bleeding.
    Barski PR
    N Engl J Med; 2005 Apr; 352(16):1716-8; author reply 1716-8. PubMed ID: 15846857
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of proton pump inhibitors in the treatment of heartburn during pregnancy.
    Christopher L
    J Am Acad Nurse Pract; 2005 Jan; 17(1):4-8. PubMed ID: 15679877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of non-antacid antiulcer agents in the treatment of heartburn and dyspepsia.
    Sena MM; Stoddard ML; Pashko S
    Clin Ther; 1994; 16(1):103-9. PubMed ID: 8205596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A therapeutic substitution policy for proton pump inhibitors: clinical and economic consequences.
    Schneeweiss S; Maclure M; Dormuth CR; Glynn RJ; Canning C; Avorn J
    Clin Pharmacol Ther; 2006 Apr; 79(4):379-88. PubMed ID: 16580906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional heartburn: what it is and how to treat it.
    Fass R
    Gastrointest Endosc Clin N Am; 2009 Jan; 19(1):23-33, v. PubMed ID: 19232278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heartburn medication side effects: should you worry? Proton pump inhibitors (PPIs) are safe for most people, but also have potential risks you should know about.
    Harv Mens Health Watch; 2013 Feb; 17(7):4. PubMed ID: 27024475
    [No Abstract]   [Full Text] [Related]  

  • 16. Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan.
    Johnson JT; Neill KK; Davis DA
    J Manag Care Pharm; 2011 Apr; 17(3):200-12. PubMed ID: 21434697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of heartburn and acid reflux associated with nausea and vomiting during pregnancy.
    Law R; Maltepe C; Bozzo P; Einarson A
    Can Fam Physician; 2010 Feb; 56(2):143-4. PubMed ID: 20154244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of proton pump inhibitors in the treatment of gastro-oesophageal reflux disease.
    Bardhan KD
    Aliment Pharmacol Ther; 1995; 9 Suppl 1():15-25. PubMed ID: 7495937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erosive esophagitis and NERD: Can we really classify patients with heartburn by endoscopic findings?
    Chey WD
    Clin Gastroenterol Hepatol; 2004 Aug; 2(8):654-5. PubMed ID: 15290656
    [No Abstract]   [Full Text] [Related]  

  • 20. Pretreatment antimicrobial susceptibility testing is not cost saving in the standard eradication of Helicobacter pylori.
    Qasim A; Sebastian S; Buckley M; O'Connor H; O'Morain C
    Clin Gastroenterol Hepatol; 2004 Jan; 2(1):85; discussion 85. PubMed ID: 15017637
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.